Last 12 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -12.84 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 6.61 | 6.08 | 6.12 | 4.49 | 5.11 | 5.47 | — | — | — | — | — | — | — |
| — | +11.3% | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 3.01 | 3.33 | 3.38 | 2.26 | 2.09 | 1.74 | — | — | — | — | — | — | — |
| — | +91.3% | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.5% | 78.5% | 78.3% | 77.7% | 76.7% | 76.2% | 69.7% | 70.3% | 77.6% | 76.5% | 76.9% | 76.8% | 79.5% |
| — | +2.9% | +12.3% | +10.6% | -1.1% | -0.3% | -9.4% | -8.5% | -2.4% | — | — | — | — | |
| Operating Margin | -55.6% | -46.9% | -58.4% | -53.7% | -59.0% | -65.0% | -53.2% | -42.4% | -40.5% | -52.1% | -48.2% | -45.3% | -35.2% |
| — | +27.8% | -9.8% | -26.8% | -45.5% | -24.8% | -10.5% | +6.5% | -15.1% | — | — | — | — | |
| Net Margin | -85.3% | -43.5% | -59.1% | -50.1% | -53.9% | -74.3% | -174.3% | -46.0% | -43.5% | -54.4% | -50.5% | -50.1% | -37.0% |
| — | +41.4% | +66.1% | -9.0% | -24.0% | -36.5% | -245.1% | +8.2% | -17.5% | — | — | — | — |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -93.8% | -5.8% | -7.9% | -6.1% | -5.4% | -8.9% | -46.1% | -17.1% | -19.2% | — | — | -10.2% | -7.3% |
| — | +34.7% | +82.9% | +64.1% | +71.9% | — | — | -66.8% | -163.2% | — | — | — | — | |
| ROA | -37.9% | -4.7% | -6.5% | -5.1% | -4.5% | -6.8% | -28.4% | -9.3% | -8.8% | — | — | — | -4.7% |
| — | +30.6% | +77.1% | +45.3% | +49.2% | — | — | — | -88.9% | — | — | — | — | |
| ROIC | -47.6% | -5.4% | -6.0% | -5.1% | -5.4% | -8.0% | -11.1% | -9.0% | -11.0% | — | — | -10.7% | — |
| — | +32.3% | +45.8% | +43.6% | +51.1% | — | — | +15.8% | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.11 | 0.13 | 0.12 | 0.11 | 0.11 | 0.10 | 0.31 | 0.42 | 0.74 | — | — | — | 0.42 |
| — | +24.6% | -61.0% | -73.4% | -85.7% | — | — | — | +78.8% | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 11.07 | 10.68 | 10.71 | 11.81 | 11.07 | 11.09 | 5.52 | 7.10 | 4.59 | — | — | — | 11.17 |
| — | -3.7% | +94.1% | +66.4% | +141.0% | — | — | — | -58.9% | — | — | — | — | |
| Quick Ratio | 9.55 | 8.69 | 8.92 | 10.04 | 9.55 | 9.80 | 4.15 | 5.22 | 2.77 | — | — | — | 8.85 |
| — | -11.3% | +115.1% | +92.3% | +245.0% | — | — | — | -68.7% | — | — | — | — | |
| Interest Coverage | -575.56 | -13.24 | — | -20.22 | -14.15 | -110.91 | -87.87 | -11.70 | -8.70 | -11.87 | -13.29 | -10.36 | -3.48 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 12 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SI stock.
Shoulder Innovations, Inc.'s current P/E is -12.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Shoulder Innovations, Inc.'s current operating margin is -55.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Shoulder Innovations, Inc.'s business trajectory between earnings reports.